Molecular mechanisms of L-DOPA-induced dyskinesia
Molecular mechanisms of L-DOPA-induced dyskinesia
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Dyskinesia is a treatment-limiting side effect of dopaminergic replacement therapies in Parkinson's disease. Here Jenner discusses what we know about the molecular causes of dyskinesia induction and expression, highlighting recent findings that suggest that altered glutamatergic transmission might be important.
Key Points
Involuntary movement...
Alternative Titles
Full title
Molecular mechanisms of L-DOPA-induced dyskinesia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_20908379
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20908379
Other Identifiers
ISSN
1471-003X
E-ISSN
1471-0048,1469-3178
DOI
10.1038/nrn2471
